CRH Work in process decreased by 10.0% to $324.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 23.7%, from $262.00M to $324.00M. Over 2 years (FY 2023 to FY 2025), Work in process shows an upward trend with a 39.1% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase may indicate production bottlenecks or scaling efforts, while a decrease suggests efficient throughput or reduced manufacturing activity.
Represents the value of goods that have entered the production process but are not yet finished. For a manufacturer like...
Peers in medical device manufacturing typically maintain lean WIP levels to optimize cash conversion cycles.
inv_work_in_progress| Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $179.00M | $192.00M | $175.00M | $186.00M | $211.00M | $200.00M | $246.00M | $267.00M | $262.00M | $270.00M | $286.00M | $360.00M | $324.00M |
| QoQ Change | — | +7.3% | -8.9% | +6.3% | +13.4% | -5.2% | +23.0% | +8.5% | -1.9% | +3.1% | +5.9% | +25.9% | -10.0% |
| YoY Change | — | — | — | — | +17.9% | +4.2% | +40.6% | +43.5% | +24.2% | +35.0% | +16.3% | +34.8% | +23.7% |
| % of Inventories | 4.0% | 4.5% | 4.2% | 4.3% | 4.6% | 4.4% | 5.3% | 5.6% | 5.3% | 5.3% | 5.7% | 6.9% | 6.4% |
| Share Change | — | +0.5pp | -0.3pp | +0.2pp | +0.2pp | -0.1pp | +0.9pp | +0.3pp | -0.3pp | +0.1pp | +0.4pp | +1.2pp | -0.5pp |